Cyclotides for Bioimaging

  • ChemPubSoc Europe Logo
  • Author: Joseph D. Unsay
  • Published Date: 30 August 2017
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Cyclotides for Bioimaging

Related Societies

Cyclotides are globular microproteins (about 28–37 amino acids) with a unique head-to-tail cyclized backbone, stabilized by three disulfide bonds (a so-called cyclic cysteine-knot motif). This motif imparts rigidity and, therefore, physical, chemical, and biological stability to the cyclotide. One such cyclotide is MCoTI-I, which is a potent antagonist of CXCR4 receptors (a receptor that plays an important role in several diseases including HIV, cancer, and lupus).

Julio A. Camarero, University of Southern California, Los Angeles, CA, USA, Sridhar Nimmgadda, Johns Hopkins University, Baltimore, MD, USA, and colleagues have developed cyclotides based on MCoTI-I as possible anticancer and bioimaging agents. The researchers incorporated a lysine conjugated with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) into the cyclotide sequence. DOTA is a chelator and able to bind radiolabels like 64Cu, which are often used for positron emission tomography (PET).


The team evaluated the affinity of the modified cyclotides to the receptor CXCR4 and found a high inhibition constant Ki of 0.15 nM, compared with >4700 nM for MCOTI-I. They then injected these cyclotides to tumor-bearing mice and were able to image the tumors.


 

Article Views: 2007

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH